Integra Lifesciences Holdings (IART) Common Equity (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Common Equity of $1.0 billion for Q2 2026, little changed sequentially from $1.0 billion in Q1 2026, and little changed YoY from $1.0 billion in Q2 2025.
Integra Lifesciences Holdings (IART) Common Equity (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Common Equity for 18 years, with the latest figure at $1.0 billion in Q2 2026.
- Quarterly Common Equity changed 0.45% year-over-year to $1.0 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.0 billion (changed 0.45% YoY) and the FY2025 annual result came in at $1.0 billion, down 32.47% from the prior year.
- Common Equity was little changed at $1.0 billion in Q2 2026 per IART's latest filing, from $1.0 billion in the prior quarter.
- Over five years, Common Equity peaked at $1.8 billion in Q4 2022 and troughed at $1.0 billion in Q3 2025.
- A 5-year average of $1.5 billion and a median of $1.6 billion in 2023 frame the typical range for Common Equity.
- The sharpest annual moves came in 2022 and 2025: Common Equity increased 7.1% in 2022, then plunged 32.47% in 2025.
- Over 5 years, Common Equity stood at $1.8 billion in 2022, then retreated by 12.0% to $1.6 billion in 2023, then declined by 2.68% to $1.5 billion in 2024, then slumped by 32.47% to $1.0 billion in 2025, then retreated by 0.01% to $1.0 billion in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $1.0 billion, $1.0 billion, and $1.0 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Integra Lifesciences Holdings | 1.28 Bn | 1.01 Bn | 219.74 Mn | 1.04 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 1.04 Bn |
| Sep 30, 2025 | 1.04 Bn |
| Jun 30, 2025 | 1.04 Bn |
| Mar 31, 2025 | 1.52 Bn |
| Dec 31, 2024 | 1.55 Bn |
| Sep 30, 2024 | 1.52 Bn |
| Jun 30, 2024 | 1.53 Bn |
| Mar 31, 2024 | 1.60 Bn |
| Dec 31, 2023 | 1.59 Bn |
| Sep 30, 2023 | 1.58 Bn |
| Jun 30, 2023 | 1.68 Bn |
| Mar 31, 2023 | 1.67 Bn |
| Dec 31, 2022 | 1.80 Bn |
| Sep 30, 2022 | 1.72 Bn |
| Jun 30, 2022 | 1.66 Bn |
| Mar 31, 2022 | 1.62 Bn |
| Dec 31, 2021 | 1.68 Bn |
| Sep 30, 2021 | 1.63 Bn |